Obesity Trial, Recruiting NCT07169136 Sponsor: Nemours Children's Clinic Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT07169136
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with Polycystic Ovary Syndrome (PCOS) based on specific criteria: irregular periods (cycles shorter than 21 days or longer than 35 days) and higher-than-normal male hormone levels, confirmed by blood tests.
  • People who are classified as obese, meaning their weight is at or above the 95th percentile for their age group.
  • Females between the ages of 12 and 18, who have had their period for at least 2 years.
  • People whose PCOS symptoms and obesity have continued despite making lifestyle changes (such as diet and exercise) for at least 4 months.
  • People who are in good overall health aside from the conditions listed above.

Who may not be able to join:

  • People whose thyroid function blood tests came back abnormal at the screening visit.
  • People with known or suspected diabetes, high fasting blood sugar, or abnormal results on a blood sugar marker test called HbA1c.
  • People with a specific hormonal condition called non-classic congenital adrenal hyperplasia.
  • People with a condition called hyperprolactinemia, which involves having too much of a hormone called prolactin in the blood.
  • People with a personal or family history of a specific type of thyroid cancer (medullary thyroid carcinoma), a related genetic condition called MEN2, or a history of pancreas inflammation (pancreatitis).
  • People who have been taking certain medications — including metformin, GLP-1 medications, the contraceptive pill, progesterone, or other insulin-sensitising medicines — for 6 weeks or more before the screening visit.
  • People who are currently pregnant or who have been pregnant at any point.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 1 + 904-408-7895

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nemours Children's Clinic
Registry
ClinicalTrials.gov
Start date
11 September 2025
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in LH pulse frequency after 4 months of GLP-1 agonist use.; Change in average levels of LH and FSH after 4 months of GLP-1 agonist use.; Change in average levels of Total testosterone and Estradiol after 4 months of GLP-1 agonist use.; Change in average levels of progesterone after 4 months of GLP-1 agonist use.; Change in LH amplitude.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov